Skitii delivers AI-based adaptive music therapy using heart rate variability (HRV) monitoring for real-time emotion regulation. The system helps cancer patients reduce treatment-related anxiety and distress through personalized, physiologically-responsive music interventions.
Founders
Ms.Darshana Jain
Healthcare / Medical Technology
The Problem:
65-85% of head and neck cancer patients experience significant anxiety and depression during treatment. Current supportive care lacks real-time, personalized interventions with objective physiological monitoring.
The Solution:
Skitii uses RMSSD-based adaptive music therapy that monitors heart rate variability in real-time and adjusts music selection to maintain optimal stress levels (RMSSD ≥30ms). The patent-filed algorithm personalizes therapy by learning individual patient responses.
Who Benefits?
- Cancer patients undergoing chemotherapy/radiotherapy
- Healthcare facilities providing supportive oncology care
- Mental health and wellness programs
Key Achievements
- Patented AI-based adaptive emotion regulation system
- Clinical trial approved at Yenepoya Medical College Hospital
- Achieved Emotion regulation of 47% in 30000+Students
Societal Impact
Skitii provides accessible, non-invasive stress reduction for cancer patients, improving quality of life during treatment and potentially enhancing treatment adherence.
Vision for the Future
- Year 1: Complete clinical trial, obtain CDSCO medical device approval (Class B)
- Year 2: Expand to multiple cancer centers across India and file for FDA and CE medical Device
- Year 3: Scale to broader applications (chronic illness, mental health, workplace wellness)
